Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiming Weng

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 28, 2024
Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective studyJia Feng, Xinyi Chen, Jiayan Wei, et al.
Aging|April 24, 2024
Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancerJinsong Wang, Jia Feng, Xinyi Chen, et al.
International Immunopharmacology|August 28, 2021
TLRs induce Th1/Th2 responses by affecting the secretion of CCL2 at the maternal-foetal interfaceNa Yu, Yiming Weng, Wei Liu, et al.
Journal of Materials Chemistry. B|April 9, 2020
Matrix metalloproteinase-triggered denuding of engineered gold nanoparticles for selective cell uptakeAnil K Suresh, Yiming Weng, Zhuo Li, et al.
Cell Transplantation|September 8, 2022
METTL3-Mediated m<sup>6</sup>A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT SignalingYuanshen Mao, Wenfeng Li, YiMing Weng, et al.
Scientific Reports|July 15, 2024
The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancerYiming Weng, Jingping Yuan, Xue Cui, et al.
Frontiers in Oncology|July 12, 2021
Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-AnalysisYao Jin, Aili Tan, Jia Feng, et al.
Frontiers in Genetics|February 23, 2023
Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapyJinsong Wang, Xue Cui, Yiming Weng, et al.
Frontiers in Immunology|February 24, 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8<sup>+</sup> T cell antitumor activityYingying Xiong, Yiming Weng, Shan Zhu, et al.
Frontiers in Oncology|March 14, 2022
Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-AnalysisYao Jin, Jiayan Wei, Yiming Weng, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 28, 2024
Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective studyJia Feng, Xinyi Chen, Jiayan Wei, et al.
Aging|April 24, 2024
Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancerJinsong Wang, Jia Feng, Xinyi Chen, et al.
International Immunopharmacology|August 28, 2021
TLRs induce Th1/Th2 responses by affecting the secretion of CCL2 at the maternal-foetal interfaceNa Yu, Yiming Weng, Wei Liu, et al.
Journal of Materials Chemistry. B|April 9, 2020
Matrix metalloproteinase-triggered denuding of engineered gold nanoparticles for selective cell uptakeAnil K Suresh, Yiming Weng, Zhuo Li, et al.
Cell Transplantation|September 8, 2022
METTL3-Mediated m<sup>6</sup>A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT SignalingYuanshen Mao, Wenfeng Li, YiMing Weng, et al.
Scientific Reports|July 15, 2024
The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancerYiming Weng, Jingping Yuan, Xue Cui, et al.
Frontiers in Oncology|July 12, 2021
Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-AnalysisYao Jin, Aili Tan, Jia Feng, et al.
Frontiers in Genetics|February 23, 2023
Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapyJinsong Wang, Xue Cui, Yiming Weng, et al.
Frontiers in Immunology|February 24, 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8<sup>+</sup> T cell antitumor activityYingying Xiong, Yiming Weng, Shan Zhu, et al.
Frontiers in Oncology|March 14, 2022
Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-AnalysisYao Jin, Jiayan Wei, Yiming Weng, et al.
Pageof 4